Holger Wesche, Chief Scientific Officer at Harpoon Therapeutics, Inc. (HARP), sold 16,900 shares at $17.32 ($314K) on 2021-01-04, disclosed to the SEC on 2021-01-06.
Open-market sale of $314k HARP by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.32 | 3,100 | $54K | 17.1% |
| 2 | $18.30 | 3,351 | $61K | 19.5% |
| 3 | $18.30 | 3,351 | $61K | 19.5% |
| 4 | $19.39 | 3,549 | $69K | 21.9% |
| 5 | $19.39 | 3,549 | $69K | 21.9% |
| Total | $18.58 avg | 16,900 |
| $314K |
| 100% |
| Filing → |
| HARP | SELL | 2020-10-05 | $163K | — | Filing → |
| HARP | SELL | 2020-07-02 | $162K | — | Filing → |
| HARP | SELL | 2020-05-13 | $20K | — | Filing → |